Conditions DEA Epilepsy THC 
The Cannigma
SEPTEMBER 12, 2021
THC is the most prevalent, famous and researched cannabinoid by far. THC is the molecule responsible for the famous high associated with marijuana, but it also has a long list of therapeutic effects. What is THC? THC is short for tetrahydrocannabinol. Who discovered THC? THC vs CBD.
Freedom Leaf
OCTOBER 15, 2018
Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 20, 2019
The compound responsible for the euphoric, mind-altering effect is tetrahydrocannabinol (THC). Department of Transportation (DOT) drug test includes THC, and its presence at defined levels constitutes a positive drug test. percent THC, they could contain high enough levels of THC to make a drug test positive.
The Joint Blog
JUNE 4, 2021
Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
Veriheal
NOVEMBER 11, 2023
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” tetrahydrocannabinol (THC) are legal. THC is the major ingredient responsible for the “highness” effect of cannabis. Is Medical Cannabis Legal?
Veriheal
APRIL 11, 2022
Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb.
Veriheal
DECEMBER 28, 2021
D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S.
Expert insights. Personalized for you.
98 
Let's personalize your content